Comment · Mon, November 23, 2015 · Ceretropic & Nootropics Depot
The case for BPC-157 as a nootropic
Original post in this thread
roybo · 44 points
### TL;DR
BPC-157 reduces tolerance to GABAergics and possibly dopaminergics. The dosage
required is much lower than current broscience would indicate.
### The case for BPC-157 as a nootropic
BPC-157 is an injectable peptide that doesn't get talked about around here but is well known over
at /r/PEDs for it's ability to accelerate the healing of injuries. After having read through
the research on pubmed and sampling it
myself, I believe it deserves more attention from the Nootropics community.
Virtually all of the studies come from a group in Croatia and they always use the same doses
in their mice and rat studies: 10 micrograms per kg and 10 nanograms per kg. Most of the studies
find some activity at the lower dose and more activity at the higher dose. This translates
to a dosage range of about 1 ng/kg to 1 mcg/kg in humans. The standard advice is to take
200 to 500 mcg for healing purposes when doses of as low as 0.1 mcg could show results.
I've been using doses in the 50-100 mcg range which is on the higher end of the experimental
range for the simple reason that if I use doses lower than that the peptide will degrade bef…
What they were answering
writofmandingus · 1 points
Ya'll going to continue selling semax?
u/MisterYouAreSoDumb · Ceretropic & Nootropics Depot
Yes, Semax is staying up.